Financial & competing interests disclosure
E Dauden has the following conflict of interests: Advisory Board member, consultant, grants, research support, participation in clinical trials, honorarium for speaking and research support with the following pharmaceutical companies: Abbott, Astellas, Biogen, Galderma, GlaxoSmithKline, Janssen-Cilag, Leo Pharma, Merck-Serono, Novartis, Schering-Plough, Wyeth Pharmaceuticals and 3M. Writing assistance was provided by Steve Clissold PhD (Content Ed Net), with funding by Schering-Plough, USA. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.